Publications by authors named "Reka Angi"

Claim this Profile
E
Effects of Different Centrifugation Parameters on Equilibrium Solubility Measurements.
Rita Szolláth, Vivien Bárdos, Marcell Stifter-Mursits, Réka Angi, Károly Mazák

Methods Protoc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Finding and Food Effect Studies of a Novel Abiraterone Acetate Formulation for Oral Suspension in Comparison to a Reference Formulation in Healthy Male Subjects.
Tamás Jordán, Orsolya Basa-Dénes, Réka Angi, János Orosz, Zsolt Ötvös

Pharmaceutics· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Escalation Study to Assess the Pharmacokinetic Parameters of a Nano-amorphous Oral Sirolimus Formulation in Healthy Volunteers.
Orsolya Basa-Dénes, Réka Angi, Balázs Kárpáti, Tamás Jordán, Zsolt Ötvös

Eur J Drug Metab Pharmacokinet· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigations of the mechanism behind the rapid absorption of nano-amorphous abiraterone acetate.
Orsolya Basa-Dénes, Tamás Solymosi, Zsolt Ötvös, Réka Angi, Andrea Ujhelyi

Eur J Pharm Sci· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preparation, Pre-clinical and Clinical Evaluation of a Novel Rapidly Absorbed Celecoxib Formulation.
Réka Angi, Tamás Solymosi, Nikoletta Erdősi, Tamás Jordán, Balázs Kárpáti

AAPS PharmSciTech· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel formulation of abiraterone acetate might allow significant dose reduction and eliminates substantial positive food effect.
Tamás Solymosi, Zsolt Ötvös, Réka Angi, Betti Ordasi, Tamás Jordán

Cancer Chemother Pharmacol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of an abiraterone acetate formulation with improved oral bioavailability guided by absorption modeling based on in vitro dissolution and permeability measurements.
Tamás Solymosi, Zsolt Ötvös, Réka Angi, Betti Ordasi, Tamás Jordán

Int J Pharm· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirolimus formulation with improved pharmacokinetic properties produced by a continuous flow method.
Tamás Solymosi, Réka Angi, Orsolya Basa-Dénes, Soma Ránky, Zsolt Ötvös

Eur J Pharm Biopharm· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel continuous flow technology for the development of a nanostructured aprepitant formulation with improved pharmacokinetic properties.
Réka Angi, Tamás Solymosi, Zsolt Ötvös, Betti Ordasi, Hristos Glavinas

Eur J Pharm Biopharm· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis